Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Triple-Negative Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Infirmary Cancer Care ( Site 0001), Mobile, Alabama, United States

    Study coordinator · 251-435-2273
  • Ironwood Cancer & Research Centers-Research ( Site 0054), Chandler, Arizona, United States

    Study coordinator · 480-821-2838
  • MemorialCare Orange Coast Medical Center ( Site 9501), Fountain Valley, California, United States

    Study coordinator · 714-378-7000
  • Scripps Cancer Center ( Site 0052), La Jolla, California, United States

    Study coordinator · 800-727-4777
  • Cancer and Blood Specialty Clinic ( Site 0008), Los Alamitos, California, United States

  • Kaiser Permanente - Oakland ( Site 0079), Oakland, California, United States

    Study coordinator · 877-642-4691
  • Profound Research LLC ( Site 0105), Oceanside, California, United States

    Study coordinator · 760-826-2020
  • Kaiser Permanente - Roseville ( Site 0081), Roseville, California, United States

    Study coordinator · 877-642-4691
  • Kaiser Permanente - San Francisco ( Site 0080), San Francisco, California, United States

    Study coordinator · 877-642-4691
  • Kaiser Permanente - Santa Clara ( Site 0082), Santa Clara, California, United States

    Study coordinator · 877-642-4691
  • Providence Medical Foundation ( Site 9543), Santa Rosa, California, United States

    Study coordinator · 707-528-1050
  • Kaiser Permanente Vallejo Medical Center ( Site 0060), Vallejo, California, United States

    Study coordinator · 877-642-4691
  • Kaiser Permanente - Walnut Creek ( Site 0078), Walnut Creek, California, United States

    Study coordinator · 877-642-4691
  • Bass Medical Group ( Site 0089), Walnut Creek, California, United States

  • Cancer Centers of Colorado St. Mary's Regional Hospital ( Site 0046), Grand Junction, Colorado, United States

    Study coordinator · 970-298-7500
  • Yale Cancer Center ( Site 0053), New Haven, Connecticut, United States

    Study coordinator · 203-688-4242
  • AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs, Florida, United States

    Study coordinator · 407-834-5151
  • Orlando Health Cancer Institute ( Site 0030), Orlando, Florida, United States

    Study coordinator · 321-843-8370
  • Comprehensive Hematology Oncology ( Site 0091), St. Petersburg, Florida, United States

    Study coordinator · 727-344-6569
  • Cleveland Clinic Martin North Hospital ( Site 0114), Stuart, Florida, United States

    Study coordinator · 772-419-2146
  • Archbold Memorial Hospital-Lewis Hall Singletary Oncology Center ( Site 0040), Thomasville, Georgia, United States

  • Illinois Cancer Specialists (ICS) ( Site 8010), Arlington Heights, Illinois, United States

    Study coordinator · 847-259-4482
  • Orchard Healthcare Research Inc. ( Site 0014), Skokie, Illinois, United States

    Study coordinator · 224-534-7580
  • Northwest Cancer Center - Dyer Clinic ( Site 0097), Dyer, Indiana, United States

    Study coordinator · 615-785-5914
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0011), Fort Wayne, Indiana, United States

    Study coordinator · 260-266-6313
  • Cancer Center of Kansas ( Site 0004), Wichita, Kansas, United States

  • Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0044), Edgewood, Kentucky, United States

    Study coordinator · 859-301-4000
  • CHRISTUS St. Frances Cabrini Hospital Center for Cancer Care ( Site 0109), Alexandria, Louisiana, United States

    Study coordinator · 318-528-6976
  • Ochsner LSU Health - Monroe Medical Center, Family Medicine Clinic ( Site 0063), Monroe, Louisiana, United States

  • Louisiana State University Health Sciences Shreveport ( Site 0029), Shreveport, Louisiana, United States

    Study coordinator · 318-813-1429
  • Holy Cross Hospital ( Site 0069), Silver Spring, Maryland, United States

    Study coordinator · 301-754-7552
  • University of Michigan ( Site 0103), Ann Arbor, Michigan, United States

    Study coordinator · 800-865-1125
  • Profound Research LLC ( Site 0074), Royal Oak, Michigan, United States

  • Metro-Minnesota Community Clinical Oncology ( Site 0031), Saint Louis Park, Minnesota, United States

    Study coordinator · 952-993-3252
  • University of Mississippi Medical Center ( Site 0043), Jackson, Mississippi, United States

    Study coordinator · 601-984-5590
  • SSM Health Cancer Care - Fenton ( Site 0088), Fenton, Missouri, United States

  • Lake Regional Hospital ( Site 0009), Osage Beach, Missouri, United States

    Study coordinator · 573-302-2772
  • Siteman Cancer Center ( Site 0099), St Louis, Missouri, United States

    Study coordinator · 314-362-0263
  • Optum Care Cancer Center ( Site 9535), Las Vegas, Nevada, United States

    Study coordinator · 702-724-8787
  • New Mexico Oncology Hematology Consultants Ltd. ( Site 0090), Albuquerque, New Mexico, United States

    Study coordinator · 505-842-8171
  • CHRISTUS St. Vincent Regional Cancer Center ( Site 0118), Santa Fe, New Mexico, United States

    Study coordinator · 505-913-8953
  • Icahn School of Medicine at Mount Sinai ( Site 0123), New York, New York, United States

    Study coordinator · 212-241-3300
  • Memorial Sloan Kettering Cancer Center ( Site 0067), New York, New York, United States

    Study coordinator · 212-639-2000
  • Clinical Research Alliance ( Site 0086), Westbury, New York, United States

    Study coordinator · 516-734-8906
  • Levine Cancer Institute ( Site 0083), Charlotte, North Carolina, United States

    Study coordinator · 980-442-3130
  • Cape Fear Valley Health System ( Site 0136), Fayetteville, North Carolina, United States

    Study coordinator · 472-210-8847
  • Sanford Cancer Center Bismarck ( Site 0058), Bismarck, North Dakota, United States

    Study coordinator · 701-323-5741
  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0056), Fargo, North Dakota, United States

    Study coordinator · 701-234-2000
  • Altru Cancer Center ( Site 0104), Grand Forks, North Dakota, United States

    Study coordinator · 701-780-5451
  • Cleveland Clinic - Mercy Hospital ( Site 0057), Canton, Ohio, United States

    Study coordinator · 330-489-1274
  • Tri-County Hematology & Oncology Associates, Inc. ( Site 0076), Massillon, Ohio, United States

    Study coordinator · 330-478-0001
  • Taylor Cancer Research Center ( Site 9500), Maumee, Ohio, United States

    Study coordinator · 567-402-4501
  • Genesis Healthcare System ( Site 0025), Zanesville, Ohio, United States

    Study coordinator · 740-454-5271
  • Hightower Clinical, LLC ( Site 0085), Oklahoma City, Oklahoma, United States

    Study coordinator · 405-479-8331
  • Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0041), Tulsa, Oklahoma, United States

    Study coordinator · 918-505-3200
  • Providence Portland Medical Center ( Site 0116), Portland, Oregon, United States

    Study coordinator · 503-215-1979
  • Providence Oncology and Hematology Care Clinic - Westside ( Site 0126), Portland, Oregon, United States

    Study coordinator · 503-215-1979
  • Sidney Kimmel Cancer Center at Jefferson ( Site 0049), Philadelphia, Pennsylvania, United States

    Study coordinator · 215-955-8874
  • Cancer Care Associates Of York ( Site 9517), York, Pennsylvania, United States

    Study coordinator · 717-741-9229
  • Sanford Cancer Center ( Site 0059), Sioux Falls, South Dakota, United States

    Study coordinator · 605-328-8000
  • West Cancer Center and Research Institute ( Site 0084), Germantown, Tennessee, United States

    Study coordinator · 901-683-0055
  • Baptist Cancer Center ( Site 0101), Memphis, Tennessee, United States

    Study coordinator · 901-226-3077
  • One Oncology - Tennessee Oncology ( Site 0098), Nashville, Tennessee, United States

    Study coordinator · 615-986-4350
  • SCRI Oncology Partners ( Site 7000), Nashville, Tennessee, United States

    Study coordinator · 615-329-7274
  • Tennessee Oncology ( Site 0111), Nashville, Tennessee, United States

    Study coordinator · 615-986-4350
  • Nashville General Hospital ( Site 0072), Nashville, Tennessee, United States

  • Vanderbilt Health One Hundred Oaks ( Site 0042), Nashville, Tennessee, United States

    Study coordinator · 800-811-8480
  • Hendrick Medical Center ( Site 0117), Abilene, Texas, United States

    Study coordinator · 325-670-2000
  • Harrington Cancer Center ( Site 0061), Amarillo, Texas, United States

    Study coordinator · 806-359-4673
  • Texas Oncology - DFW ( Site 8000), Dallas, Texas, United States

    Study coordinator · 214-370-1000
  • Parkland Health & Hospital System ( Site 0096), Dallas, Texas, United States

    Study coordinator · 214-645-4673
  • University of Texas Southwestern Medical Center ( Site 0032), Dallas, Texas, United States

    Study coordinator · 214-645-4673
  • Texas Oncology - Northeast Texas ( Site 8005), Flower Mound, Texas, United States

    Study coordinator · 972-537-4100
  • John Peter Smith Hospital ( Site 0106), Fort Worth, Texas, United States

    Study coordinator · 817-702-8049
  • Oncology Consultants P.A. ( Site 0107), Houston, Texas, United States

    Study coordinator · 713-600-0900
  • Laguna Clinical Research Associates LLC ( Site 0068), Laredo, Texas, United States

    Study coordinator · 956-724-8543
  • Mays Cancer Center ( Site 0122), San Antonio, Texas, United States

    Study coordinator · 210-450-1000
  • The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0055), Tyler, Texas, United States

    Study coordinator · 903-592-6152
  • Texas Oncology - Gulf Coast ( Site 8009), Webster, Texas, United States

    Study coordinator · 281-332-7505
  • Intermountain Medical Center ( Site 0113), Murray, Utah, United States

    Study coordinator · 801-507-3630
  • Mary Washington Hospital ( Site 0129), Fredericksburg, Virginia, United States

    Study coordinator · 540-300-6182
  • Hematology Oncology Associates of Fredericksburg ( Site 9550), Fredericksburg, Virginia, United States

    Study coordinator · 540-371-0079
  • Bon Secours Memorial Regional Medical Center-Oncology Research Department ( Site 0020), Midlothian, Virginia, United States

    Study coordinator · 804-893-8717
  • Virginia Oncology Associates (VOA) ( Site 8008), Norfolk, Virginia, United States

    Study coordinator · 646-694-8125
  • Virginia Cancer Institute ( Site 0034), Richmond, Virginia, United States

    Study coordinator · 804-287-3000
  • Northwest Medical Specialties, PLLC ( Site 0093), Tacoma, Washington, United States

    Study coordinator · 253-428-8700
  • SSM Health Dean Medical Group ( Site 0087), Madison, Wisconsin, United States

    Study coordinator · 516-488-2918
  • Hospital Aleman-Oncology ( Site 0501), Capital Federal, Buenos Aires, Argentina

    Study coordinator · +541148277000
  • Hospital Británico de Buenos Aires-Oncology ( Site 0502), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · +54911563819972
  • Instituto de Oncología Angel H. Roffo ( Site 0503), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · 5491152375236
  • Instituto Alexander Fleming-Alexander Fleming ( Site 0509), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +5491138850425
  • Sanatorio Parque ( Site 0512), Rosario, Santa Fe Province, Argentina

    Study coordinator · 543414929663
  • Sanatorio Finochietto ( Site 0513), Buenos Aires, Argentina

    Study coordinator · +54 113752-8000
  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0508), Buenos Aires, Argentina

    Study coordinator · +541152991580
  • Macquarie University-MQ Health Clinical Trials Unit ( Site 2703), Macquarie University, New South Wales, Australia

    Study coordinator · +61298122979
  • Westmead Hospital ( Site 2700), Westmead, New South Wales, Australia

    Study coordinator · +61288906728
  • Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Site 2701), Brisbane, Queensland, Australia

    Study coordinator · +610736470209
  • Frankston Hospital-Oncology and Haematology ( Site 2704), Frankston, Victoria, Australia

    Study coordinator · +61397847777
  • Medizinische Universitaet Innsbruck ( Site 1200), Innsbruck, Tyrol, Austria

    Study coordinator · +435050423079
  • Kepler Universitätsklinikum-Department for Oncology and Hematology ( Site 1206), Linz, Upper Austria, Austria

    Study coordinator · +43576808373652
  • Klinikum Wels-Grieskirchen ( Site 1205), Wels, Upper Austria, Austria

    Study coordinator · +4372424150
  • Uniklinikum Salzburg-Universitätsklinik für Innere Medizin III der PMU mit Hämatologie, internistis ( Site 1202), Salzburg, Austria

    Study coordinator · +435725525826
  • Medizinische Universität Wien-Universitätsklinik für Innere Medizin I, Klinische Abteilung für Onko ( Site 1201), Vienna, Austria

    Study coordinator · +4314040064470
  • Cliniques universitaires Saint-Luc-Medical Oncology ( Site 0901), Brussels, Bruxelles-Capitale, Region de, Belgium

    Study coordinator · 02 764 42 14
  • AZ Maria Middelares-IKG ( Site 0903), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +3292468464
  • Université Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 0902), Namur, Belgium

    Study coordinator · +32 (0)81 42 38 53
  • PRONUTRIR-CLINICAL RESEARCH ( Site 0609), Fortaleza, Ceará, Brazil

    Study coordinator · +558530480533
  • Oncoclínica Oncologistas Associados-Clinical Research ( Site 0607), Teresina, Piauí, Brazil

    Study coordinator · +5586999007799
  • Hospital do Câncer Mãe de Deus ( Site 0604), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133072943
  • Instituto de Oncologia Saint Gallen ( Site 0614), Santa Cruz do Sul, Rio Grande do Sul, Brazil

    Study coordinator · +55513056-8686
  • Instituto do Câncer Brasil - Unidade Taubaté ( Site 0608), Taubaté, São Paulo, Brazil

    Study coordinator · +551236318559
  • IBCC - Núcleo de Pesquisa e Ensino ( Site 0601), São Paulo, Brazil

    Study coordinator · +551144500300
  • Cross Cancer Institute ( Site 0407), Edmonton, Alberta, Canada

    Study coordinator · 7804328956
  • BC Cancer Vancouver ( Site 0404), Vancouver, British Columbia, Canada

    Study coordinator · 6048776000
  • CancerCare Manitoba ( Site 0411), Winnipeg, Manitoba, Canada

    Study coordinator · 2047872127
  • The Moncton Hospital ( Site 0401), Moncton, New Brunswick, Canada

    Study coordinator · 5068575756
  • QEII Health Sciences Centre - Victoria General Site ( Site 0418), Halifax, Nova Scotia, Canada

    Study coordinator · 9024732160
  • Southlake Health ( Site 0413), Newmarket, Ontario, Canada

    Study coordinator · 9058954521x5155
  • The Ottawa Hospital - General Campus ( Site 0414), Ottawa, Ontario, Canada

    Study coordinator · 6137377700x70208
  • North York General Hospital ( Site 0415), Toronto, Ontario, Canada

    Study coordinator · 4167566000
  • Princess Margaret Cancer Centre ( Site 0400), Toronto, Ontario, Canada

    Study coordinator · 4169464501x2245
  • Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0417), Greenfield Park, Quebec, Canada

    Study coordinator · 4504665000x3226
  • CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0419), Montreal, Quebec, Canada

    Study coordinator · 5142523400x6244
  • Centre Hospitalier de l'Université de Montréal ( Site 0403), Montreal, Quebec, Canada

    Study coordinator · 5148908000
  • Jewish General Hospital ( Site 0416), Montreal, Quebec, Canada

    Study coordinator · 5143405222x27562
  • Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0409), Rimouski, Quebec, Canada

    Study coordinator · 4187243000x8029
  • Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0406), Trois-Rivières, Quebec, Canada

    Study coordinator · 8196973333x63238
  • Clinica Somer ( Site 3704), Rionegro, Antioquia, Colombia

    Study coordinator · 57 3125891661
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 3700), Bogotá, Bogota D.C., Colombia

    Study coordinator · +573183662238
  • Instituto Nacional De Cancerologia ( Site 3701), Bogotá, Bogota D.C., Colombia

    Study coordinator · 57 3145017596
  • Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 3705), Valledupar, Cesar Department, Colombia

    Study coordinator · +5715602310
  • Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 1005), Brno, Brno-mesto, Czechia

    Study coordinator · +420543134000
  • Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 1006), Olomouc, Olomouc Region, Czechia

    Study coordinator · +420588444295
  • Vseobecna fakultni nemocnice v Praze-Onkologická klinika VFN ( Site 1002), Prague, Praha 2, Czechia

    Study coordinator · +420224966763
  • Fakultni Thomayerova nemocnice - Onkologicka klinika 1. LF UK a FTN ( Site 1008), Prague, Praha 4, Czechia

    Study coordinator · +420261083733
  • Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 1000), Prague, Praha 5, Czechia

    Study coordinator · +420224434701
  • Nemocnice Ceske Budejovice-Onkologicke oddeleni ( Site 1007), České Budějovice, South Bohemian Region, Czechia

    Study coordinator · +420387875001
  • Herlev og Gentofte Hospital. ( Site 3203), Herlev, Capital Region, Denmark

    Study coordinator · 00 45 38689193
  • Aarhus Universitets hospital ( Site 3202), Aarhus N, Central Jutland, Denmark

    Study coordinator · +4578450000
  • Aalborg Universitetshospital, Syd ( Site 3206), Aalborg, North Denmark, Denmark

    Study coordinator · +4597661400
  • Odense Universitetshospital ( Site 3201), Odense C, Region Syddanmark, Denmark

    Study coordinator · +4566113333
  • Sygehus Soenderjylland ( Site 3204), Sønderborg, Region Syddanmark, Denmark

    Study coordinator · +4579970000
  • Vejle Sygehus. ( Site 3205), Vejle, Region Syddanmark, Denmark

    Study coordinator · 00 45 79406060
  • Kuopion Yliopistollinen Sairaala-Syöpäkeskus ( Site 1101), Kuopio, Northern Savonia, Finland

    Study coordinator · +35817173311
  • Tampereen yliopistollinen sairaala ( Site 1102), Tampere, Pirkanmaa, Finland

    Study coordinator · +358331166764
  • Turku University Hospital-Department of Oncology ( Site 1103), Turku, Southwest Finland, Finland

    Study coordinator · +35823130721
  • Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 1100), Helsinki, Uusimaa, Finland

    Study coordinator · +358947174900
  • Centre Antoine-Lacassagne ( Site 1308), Nice, Alpes-Maritimes, France

    Study coordinator · +33492031000
  • Centre Hospitalier de la Côte Basque ( Site 1315), Bayonne, Aquitaine, France

    Study coordinator · +33559443762
  • CENTRE LEON BERARD ( Site 1300), Lyon Cedex08, Auvergne-Rhône-Alpes, France

    Study coordinator · +33478782644
  • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 1307), Clermont-Ferrand, Auvergne, France

    Study coordinator · 0473278005
  • Institut Paoli-Calmettes ( Site 1309), Marseille, Bouches-du-Rhone, France

    Study coordinator · +33491223611
  • Centre François Baclesse ( Site 1318), Caen, Calvados, France

    Study coordinator · +33231455050
  • Centre Georges François Leclerc ( Site 1312), Dijon, Cote-d Or, France

    Study coordinator · 03 70 63 24 03
  • CHU Besançon ( Site 1311), Besançon, Doubs, France

  • Hôpital Privé Drôme-Ardèche ( Site 1301), Valence, Drome, France

    Study coordinator · +33475756604
  • CHRU Brest - Hopital Cavale Blanche ( Site 1304), Brest, Finistere, France

    Study coordinator · +33230338161
  • Clinique Tivoli Ducos ( Site 1322), Bordeaux, Gironde, France

    Study coordinator · +33556116296
  • Hôpital Franco-Britannique - Fondation Cognacq-Jay ( Site 1321), Levallois-Perret, Hauts-de-Seine, France

    Study coordinator · +33147591915
  • Institut de Cancérologie de l'Ouest ( Site 1305), Saint-Herblain, Loire-Atlantique, France

    Study coordinator · +33240679900
  • Institut de Cancérologie de l'Ouest ( Site 1316), Angers, Maine-et-Loire, France

    Study coordinator · 02 41 35 27 00
  • Centre de Cancerologie Les Dentellieres ( Site 1306), Valenciennes, Nord, France

    Study coordinator · +33327091010
  • Centre Hospitalier de Pau ( Site 1302), Pau, Pyrenees-Atlantiques, France

    Study coordinator · +33559726996
  • Centre Henri Becquerel ( Site 1319), Rouen, Seine-Maritime, France

    Study coordinator · 02 32 08 22 22
  • Hôpital Tenon ( Site 1303), Paris, France

    Study coordinator · +33156017825
  • Klinikum Ludwigsburg-Klinik für Geburtshilfe und Frauenheilkunde ( Site 1405), Ludwigsburg, Baden-Wurttemberg, Germany

    Study coordinator · +4971419996433
  • Universitaetsklinikum Tuebingen-Frauenklinik ( Site 1415), Tübingen, Baden-Wurttemberg, Germany

    Study coordinator · +4970712964226
  • Universitaetsklinikum Erlangen-Klinik für Gynäkologie und Geburtshilfe ( Site 1400), Erlangen, Bavaria, Germany

    Study coordinator · +4991318533572
  • Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Frauenklinik Brustzentrum ( Site 1402), Munich, Bavaria, Germany

    Study coordinator · +4989440034645
  • Klinikum Ernst von Bergmann-Frauenklinik ( Site 1408), Potsdam, Brandenburg, Germany

    Study coordinator · +493312415602
  • Franziskus-Hospital Harderberg ( Site 1404), Georgsmarienhütte, Lower Saxony, Germany

    Study coordinator · +495415022466
  • Universitaetsklinikum Duesseldorf-Klinik für Frauenheilkunde & Geburtshilfe ( Site 1409), Düsseldorf, North Rhine-Westphalia, Germany

    Study coordinator · +492118117506
  • Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung-Klinik für Senologie/ Brustzentrum ( Site 1401), Essen, North Rhine-Westphalia, Germany

    Study coordinator · +4920117433005
  • Evangelisches Krankenhaus Bethesda Mönchengladbach-Brustzentrum Niederrhein ( Site 1406), Mönchengladbach, North Rhine-Westphalia, Germany

    Study coordinator · +4921618493577
  • Universitätsmedizin Johannes Gutenberg Universität Mainz-Klinik und Poliklinik für Geburtshilfe und ( Site 1418), Mainz, Rhineland-Palatinate, Germany

    Study coordinator · +496131172683
  • CaritasKlinikum Saarbruecken St. Theresia ( Site 1410), Saarbrücken, Saarland, Germany

    Study coordinator · +496814061345
  • Universitätsklinikum Schleswig-Holstein ( Site 1411), Lübeck, Schleswig-Holstein, Germany

    Study coordinator · +4945150041930
  • Helios Klinikum Berlin-Buch-Klinik für Gynäkologie und Geburtshilfe ( Site 1413), Berlin, Germany

    Study coordinator · +4930940113394
  • UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1509), Pátrai, Achaia, Greece

    Study coordinator · +302610999791
  • Errikos Dunant Hospital Center-1st Medical Oncology Dept. ( Site 1508), Athens, Attica, Greece

    Study coordinator · +302106972433
  • Aretaieio Hospital Oncology Unit ( Site 1505), Athens, Attica, Greece

    Study coordinator · +302107286444
  • University General Hospital of Larissa ( Site 1503), Larissa, Thessaly, Greece

    Study coordinator · +302413502785
  • European Interbalkan Medical Center ( Site 1502), Thessaloniki, Greece

    Study coordinator · +302313252011
  • European Interbalkan Medical Center ( Site 1507), Thessaloniki, Greece

    Study coordinator · +302310390671
  • Queen Mary Hospital ( Site 3600), Hong Kong, Hong Kong

    Study coordinator · +852 2255 3838
  • Hong Kong United Oncology Centre ( Site 3601), Kowloon, Hong Kong

    Study coordinator · +852 2386 8002
  • Prince of Wales Hospital ( Site 3602), Shatin, Hong Kong

    Study coordinator · + 852 3505 2211
  • Bon Secours Cork Hospital ( Site 1600), Cork, Ireland

    Study coordinator · +353214542807
  • St. Vincent's University Hospital-Medical Oncology Research Department ( Site 1601), Dublin, Ireland

    Study coordinator · +353 1 221 4982
  • University College Hospital - Galway ( Site 1602), Galway, Ireland

    Study coordinator · +35391524222
  • Soroka Medical Center-Oncology ( Site 1704), Beersheba, Israel

    Study coordinator · 0507425629
  • Shaare Zedek Medical Center ( Site 1706), Jerusalem, Israel

    Study coordinator · +97226555999
  • Hadassah Medical Center ( Site 1700), Jerusalem, Israel

    Study coordinator · +972-2-6778510
  • Rabin Medical Center ( Site 1702), Petah Tikva, Israel

    Study coordinator · +972-3-9378076
  • Sheba Medical Center-ONCOLOGY ( Site 1701), Ramat Gan, Israel

    Study coordinator · +972-35304436
  • Sourasky Medical Center ( Site 1705), Tel Aviv, Israel

    Study coordinator · +972-3-6947557
  • University of Naples Federico II-Dipartimento di Medicina Clinica e Chirurgia ( Site 1803), Naples, Campania, Italy

    Study coordinator · +390817463772
  • Istituto Nazionale Tumori IRCCS Fondazione Pascale-S.C. Oncologia Clinica Sperimentale di Senologia ( Site 1800), Naples, Campania, Italy

    Study coordinator · +3908117770442
  • Humanitas Istituto Clinico Catanese ( Site 1811), Misterbianco, Catania, Italy

    Study coordinator · +39 9573390197
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 1807), Meldola (FC), Forli-Cesena, Italy

    Study coordinator · +39 0543 739100
  • CRO-IRCCS ( Site 1808), Aviano, Friuli Venezia Giulia, Italy

    Study coordinator · +39 0434659253
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1802), Rome, Lazio, Italy

    Study coordinator · +390630158545
  • Azienda Ospedaliera Spedali Civili di Brescia ( Site 1812), Brescia, Lombardy, Italy

    Study coordinator · +390303996536
  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1801), Milan, Lombardy, Italy

    Study coordinator · +390223902597
  • Istituto Europeo di Oncologia IRCCS-Divisione di Senologia Medica ( Site 1809), Milan, Lombardy, Italy

    Study coordinator · 02 57489970
  • Fondazione IRCCS San Gerardo dei Tintori ( Site 1813), Monza, Lombardy, Italy

    Study coordinator · +39 0392339037
  • Azienda Ospedaliera Universitaria Careggi ( Site 1805), Florence, Tuscany, Italy

    Study coordinator · +390057947264
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1810), Bologna, Italy

    Study coordinator · +39 0512144548
  • Ospedale San Raffaele-Oncologia Medica ( Site 1814), Milan, Italy

    Study coordinator · +390226436530
  • Azienda Ospedaliero Universitaria Maggiore della Carità-SCDU ONCOLOGIA ( Site 1804), Novara, Italy

    Study coordinator · +3903213733822
  • Nagoya City University Hospital ( Site 3414), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-858-7215
  • National Cancer Center Hospital East ( Site 3403), Kashiwa, Chiba, Japan

    Study coordinator · +81-4-7133-1111
  • Hokkaido University Hospital ( Site 3400), Sapporo, Hokkaido, Japan

    Study coordinator · +81-11-716-1161
  • Tokai University Hospital ( Site 3413), Isehara, Kanagawa, Japan

    Study coordinator · +81-463-93-1121
  • St. Marianna University Hospital ( Site 3405), Kawasaki, Kanagawa, Japan

    Study coordinator · +81-44-977-8111
  • Kitasato University Hospital ( Site 3411), Sagamihara, Kanagawa, Japan

    Study coordinator · +81-42-778-8111
  • Kanagawa Cancer Center ( Site 3412), Yokohama, Kanagawa, Japan

    Study coordinator · +81-45-520-2222
  • Mie University Hospital ( Site 3423), Tsu, Mie-ken, Japan

    Study coordinator · +81-59-231-5246
  • Tohoku University Hospital ( Site 3422), Sendai, Miyagi, Japan

    Study coordinator · +81-22-717-7000
  • The University of Osaka Hospital ( Site 3416), Suita, Osaka, Japan

    Study coordinator · +81-6-6210-8290
  • Saitama Medical University International Medical Center ( Site 3402), Hidaka, Saitama, Japan

    Study coordinator · +81-42-984-4111
  • Juntendo University Hospital ( Site 3408), Bunkyo, Tokyo, Japan

    Study coordinator · +81-3-3813-3111
  • St.Luke's International Hospital ( Site 3427), Chūō, Tokyo, Japan

    Study coordinator · 03-3541-5151
  • Cancer Institute Hospital of JFCR ( Site 3404), Koto, Tokyo, Japan

    Study coordinator · +81-3-3520-0111
  • Showa Medical University Hospital ( Site 3406), Shinagawa, Tokyo, Japan

    Study coordinator · +81-3-3784-8000
  • Tokyo Medical University Hospital ( Site 3407), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3342-6111
  • National Center for Global Health and Medicine ( Site 3409), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3202-7181
  • Fukushima Medical University Hospital ( Site 3401), Fukushima, Japan

    Study coordinator · +81-24-547-1111
  • Gifu University Hospital ( Site 3426), Gifu, Japan

    Study coordinator · +81-58-230-6000
  • Hiroshima City Hiroshima Citizens Hospital ( Site 3418), Hiroshima, Japan

    Study coordinator · +81-82-221-2291
  • Social medical corporation Hakuaikai Sagara Hospital ( Site 3421), Kagoshima, Japan

    Study coordinator · +81-99-224-1800
  • Kumamoto University Hospital ( Site 3420), Kumamoto, Japan

    Study coordinator · +81-96-344-2111
  • Kyoto University Hospital ( Site 3415), Kyoto, Japan

    Study coordinator · +81-75-751-3111
  • Okayama University Hospital ( Site 3425), Okayama, Japan

    Study coordinator · +81-86-223-7151
  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 3417), Osaka, Japan

    Study coordinator · +81-6-6945-1181
  • Prince Court Medical Centre ( Site 2802), Kuala Lumpur, Malaysia

    Study coordinator · +60321600000
  • Pantai Hospital Kuala Lumpur ( Site 2801), Kuala Lumpur, Malaysia

    Study coordinator · +60327814519
  • CENEIT Oncologicos ( Site 0706), Mexico City, Mexico City, Mexico

    Study coordinator · 5514817472
  • Grupo Médico ASSET ( Site 0705), Mexico City, Mexico City, Mexico

    Study coordinator · 5516217417
  • Health Pharma Professional Research S.A. de C.V: ( Site 0709), Mexico City, Mexico City, Mexico

    Study coordinator · +525575864856
  • COI Centro Oncologico Internacional S.A.P.I. de C.V. ( Site 0712), Mexico City, Mexico City, Mexico

    Study coordinator · +528008773264
  • Oncare - Unidad Valle ( Site 0713), San Pedro Garza García, Nuevo León, Mexico

    Study coordinator · +528182188555
  • CENTRO MEDICO ZAMBRANO HELLION ( Site 0711), San Pedro Garza García, Nuevo León, Mexico

    Study coordinator · +528188880000
  • Drammen Sykehus, Vestre Viken HF ( Site 2001), Drammen, Buskerud, Norway

    Study coordinator · +4732803000
  • Stavanger Universitetssykehus ( Site 2004), Stavanger, Rogaland, Norway

    Study coordinator · +4751518000
  • Oslo universitetssykehus, Radiumhospitalet ( Site 2002), Oslo, Norway

    Study coordinator · +4722934000
  • Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2102), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

    Study coordinator · +48523743029
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 2120), Krakow, Lesser Poland Voivodeship, Poland

    Study coordinator · +48225462758
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Piersi i Chirurgii ( Site 2100), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · +48225462486
  • Mazowiecki Szpital Onkologiczny-BREAST CANCER ( Site 2101), Wieliszew, Masovian Voivodeship, Poland

    Study coordinator · +48227661501
  • Bialostockie Centrum Onkologii ( Site 2105), Bialystok, Podlaskie Voivodeship, Poland

  • Szpitale Pomorskie Sp. z o. o.-Oddział Onkologii Klinicznej ( Site 2113), Gdynia, Pomeranian Voivodeship, Poland

    Study coordinator · +48587260105
  • Narodowy Instytut Onkologii - Oddzial w Gliwicach-Centrum Diagnostyki i Leczenia Chorob Piersi ( Site 2110), Gliwice, Silesian Voivodeship, Poland

    Study coordinator · +48322788721
  • Zachodniopomorskie Centrum Onkologii ( Site 2108), Szczecin, West Pomeranian Voivodeship, Poland

    Study coordinator · +48914251544
  • Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch ( Site 2118), Kielce, Świętokrzyskie Voivodeship, Poland

    Study coordinator · +48885997850
  • Unidade Local de Saude Amadora/Sintra - Hospital Prof Dr Fernando Fonseca ( Site 2203), Amadora, Lisbon District, Portugal

    Study coordinator · 00351214348200
  • Fundacao Champalimaud ( Site 2200), Lisbon, Portugal

    Study coordinator · 00351210480200
  • Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 2201), Lisbon, Portugal

    Study coordinator · 00351217805000
  • Instituto Portugues de Oncologia do Porto ( Site 2202), Porto, Portugal

    Study coordinator · 00351225084000
  • National Cancer Centre Singapore-Medical Oncology ( Site 3002), Singapore, Central Singapore, Singapore

    Study coordinator · +6564368000
  • Seoul National University Hospital-Internal Medicine ( Site 3102), Seoul, South Korea

    Study coordinator · +82-2-2072-0850
  • Severance Hospital, Yonsei University Health System-Medical oncology ( Site 3100), Seoul, South Korea

    Study coordinator · +82-2-2228-8135
  • Asan Medical Center-Department of Oncology ( Site 3103), Seoul, South Korea

    Study coordinator · +8-2-3010-3216
  • Gangnam Severance Hospital, Yonsei University Health System-Medical Oncology, Internal Medicine ( Site 3104), Seoul, South Korea

    Study coordinator · +82-2-2019-3379
  • Samsung Medical Center-Division of Hematology/Oncology ( Site 3101), Seoul, South Korea

    Study coordinator · +82-2-3410-6488
  • HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 2304), Seville, Andalusia, Spain

    Study coordinator · 34955013068
  • Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2305), L'Hospitalet de Llobregat, Barcelona, Spain

    Study coordinator · +34 93 260 77 44
  • CHUAC-Hospital Teresa Herrera-MEDICAL ONCOLOGY ( Site 2307), A Coruña, La Coruna, Spain

    Study coordinator · +34981178000
  • Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 2301), Madrid, Madrid, Comunidad de, Spain

    Study coordinator · +34913368263
  • HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA-Medical Oncology ( Site 2308), Majadahonda, Madrid, Comunidad de, Spain

    Study coordinator · +34911917358
  • Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2303), Valencia, Valenciana, Comunitat, Spain

    Study coordinator · +93663224875
  • Hospital Universitari Vall d'Hebron-Oncology ( Site 2300), Barcelona, Spain

    Study coordinator · +34932746000/ 4691
  • Hospital Beata María Ana-oncology ( Site 2309), Madrid, Spain

    Study coordinator · +34914097423
  • Hospital Clinico San Carlos-Oncology Department ( Site 2306), Madrid, Spain

    Study coordinator · 34 913303000x7768
  • HOSPITAL CLINICO DE VALENCIA-Oncology ( Site 2302), Valencia, Spain

    Study coordinator · +34961973583
  • Gävle sjukhus ( Site 3504), Gävle, Gävleborg County, Sweden

    Study coordinator · +4626154000
  • Capio St. Gorans Sjukhus ( Site 3503), Stockholm, Stockholm County, Sweden

    Study coordinator · +46858701000
  • Karolinska Universitetssjukhuset Solna ( Site 3500), Stockholm, Stockholm County, Sweden

    Study coordinator · +46851770000
  • Akademiska Sjukhuset ( Site 3501), Uppsala, Uppsala County, Sweden

    Study coordinator · +46186110000
  • Södra Älvsborg Sjukhus ( Site 3502), Borås, Västra Götaland County, Sweden

    Study coordinator · +46336161000
  • Sahlgrenska Universitetssjukhuset. ( Site 3505), Gothenburg, Västra Götaland County, Sweden

    Study coordinator · +46313428503
  • Spital Thun ( Site 2400), Thun, Canton of Bern, Switzerland

    Study coordinator · +41 58 636 22 27
  • Clinique Générale-Beaulieu ( Site 2406), Geneva, Canton of Geneva, Switzerland

    Study coordinator · +41228395798
  • Brust-Zentrum ( Site 2401), Zurich, Canton of Zurich, Switzerland

    Study coordinator · +41445338141
  • Kantonsspital Graubünden-Medizin ( Site 2404), Chur, Kanton Graubünden, Switzerland

  • HFR Fribourg - Hôpital Cantonal ( Site 2402), Fribourg, Switzerland

    Study coordinator · +41263062260
  • Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2501), Adana, Turkey (Türkiye)

    Study coordinator · +90 322 459 2222
  • Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi-oncology ( Site 2504), Ankara, Turkey (Türkiye)

    Study coordinator · 03123360909
  • Memorial Ankara Hastanesi-Medical Oncology ( Site 2502), Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 253 6666
  • Medipol Mega Universite Hastanesi-oncology ( Site 2503), Istanbul, Turkey (Türkiye)

    Study coordinator · 444 70 44 - 17067
  • Samsun Medical Park Hastanesi-medical oncology ( Site 2500), Samsun, Turkey (Türkiye)

    Study coordinator · 03623114040
  • University Hospitals Bristol NHS Foundation Trust ( Site 2601), Bristol, Bristol, City of, United Kingdom

    Study coordinator · 441173426733
  • The Royal Cornwall Hospital ( Site 2603), Truro, England, United Kingdom

    Study coordinator · 01872258345
  • St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 2602), London, London, City of, United Kingdom

    Study coordinator · +44 20 7377 7000
  • University College London Hospital ( Site 2604), London, London, City of, United Kingdom

    Study coordinator · +44 20 3456 7890
  • Western General Hospital ( Site 2607), Edinburgh, Midlothian, United Kingdom

    Study coordinator · 0300 123 1600
  • St James's University Hospital-Leeds Cancer Centre ( Site 2608), Leeds, United Kingdom

    Study coordinator · 0113 243 3144
מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC